Related references
Note: Only part of the references are listed.Estimating the cost-effectiveness of screening for hepatitis C virus infection in Japan
Kota Nagai et al.
HEPATOLOGY RESEARCH (2020)
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting
Radha K. Dhiman et al.
JOURNAL OF HEPATOLOGY (2019)
Real-world cost-effectiveness of pangenotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India
Yashika Chugh et al.
PLOS ONE (2019)
The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey
Ajit Sood et al.
PLOS ONE (2018)
Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review
Jamison Pike et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2018)
Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India
Shankar Prinja et al.
PHARMACOECONOMICS-OPEN (2018)
Trends in catastrophic health expenditure in India: 1993 to 2014
Anamika Pandey et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2018)
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
Rebecca Lee et al.
HEPATOLOGY INTERNATIONAL (2017)
Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature
Weiming Tang et al.
BMC INFECTIOUS DISEASES (2017)
Cost-Effectiveness of Human Papillomavirus Vaccination for Adolescent Girls in Punjab State: Implications for India's Universal Immunization Program
Shankar Prinja et al.
CANCER (2017)
Cost of Delivering Health Care Services in Public Sector Primary and Community Health Centres in North India
Shankar Prinja et al.
PLOS ONE (2016)
Tackling the Hepatitis C Disease Burden in Punjab, India
Radha K. Dhiman et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2016)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa
Monisha Sharma et al.
NATURE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Systematic Review of the State of Economic Evaluation for Health Care in India
Shankar Prinja et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2015)
Diagnostic Accuracy of Point-of-Care Tests for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis
Mehnaaz Sultan Khuroo et al.
PLOS ONE (2015)
Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence
David D. Kim et al.
GLOBAL PUBLIC HEALTH (2015)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Budget Impact Analysis Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
Sean D. Sullivan et al.
VALUE IN HEALTH (2014)
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India
Pankaj Puri et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C A Systematic Review and Meta-analysis
Sushmita Shivkumar et al.
ANNALS OF INTERNAL MEDICINE (2012)
Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C
Phillip O. Coffin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
Andrew H. Briggs et al.
VALUE IN HEALTH (2012)
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
William Sievert et al.
LIVER INTERNATIONAL (2011)
Integrating HIV Screening into Routine Health Care in Resource-Limited Settings
Ingrid V. Bassett et al.
CLINICAL INFECTIOUS DISEASES (2010)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
Hla-Hla Thein et al.
HEPATOLOGY (2008)
Exploring uncertainty in cost-effectiveness analysis
Karl Claxton
PHARMACOECONOMICS (2008)
Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities
Emmanuela Gakidou et al.
PLOS MEDICINE (2008)
Principles of good practice for budget impact analysis: Report of the ISPOR task force on good research practices - budget impact analysis
Josephine A. Mauskopf et al.
VALUE IN HEALTH (2007)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Natural history of decompensated hepatitis C virus-related cirrhosis.: A study of 200 patients
R Planas et al.
JOURNAL OF HEPATOLOGY (2004)
Share Paper
